---
title: "August Debouzy advises Clariane on its exit from VivaSon and the shareholding reorganisation of the hearing care brand"
id: "7832"
type: "post"
slug: "august-debouzy-advises-clariane-on-its-exit-from-vivason-and-the-shareholding-reorganisation-of-the-hearing-care-brand"
published_at: "2026-06-16T10:55:44+00:00"
modified_at: "2026-07-01T08:16:13+00:00"
url: "https://www.august-debouzy.com/en/deal/august-debouzy-advises-clariane-on-its-exit-from-vivason-and-the-shareholding-reorganisation-of-the-hearing-care-brand/"
markdown_url: "https://www.august-debouzy.com/en/deal/august-debouzy-advises-clariane-on-its-exit-from-vivason-and-the-shareholding-reorganisation-of-the-hearing-care-brand.md"
taxonomy_category:
  - "Deal"
taxonomy_language:
  - "English"
taxonomy_post_translations:
  - "pll_6a312bb04c66e"
taxonomy_tax_expertise:
  - "Mergers & Acquisitions"
taxonomy_tax_secteur:
  - "Life sciences & Healthcare"
---

Summarize with AI

August Debouzy advised Clariane in connection with the sale of its minority stake in VivaSon Group, an independent French hearing care brand.

This transaction forms part of the reorganisation of VivaSon’s shareholding structure, with the strengthening of the founding family’s position and the entry of Indigo Capital alongside management.

Clariane is the leading European care community in times of vulnerability. It operates in six countries: Germany, Belgium, Spain, France, Italy and the Netherlands. Drawing on their diverse expertise, the Group’s 70,000 employees support more than 840,000 residents and patients each year across two main areas of activity: care for older people and those in vulnerable situations, through its networks of nursing homes and alternative housing solutions (Korian, Âges & Vie, Rosorum, etc.), and specialised care, including medical and rehabilitation care as well as mental health services (Inicea, Kormed, Iterias, Grupo 5, etc.).

Clariane is a “*société à mission”*under French law, with a purpose common to all its activities: “Caring for each person’s humanity in times of vulnerability.”

Clariane has been listed on Euronext Paris, Compartment B, since November 2006. The Group joined the SBF 120 index and the CAC® SBT 1.5° index on 23 September 2024.

The August Debouzy team advising Clariane was composed of **Julien Wagmann** (partner) and **François Richard** (senior associate) on the transactional aspects of the operation.

Share

- Linkedin
- Copy Link

Summarize with AI

### Authors

2

- [Julien Wagmann](https://www.august-debouzy.com/en/collaborateur/julien-wagmann/)
- [François Richard](https://www.august-debouzy.com/en/collaborateur/francois-richard/)

### Practice Area

1

- [Mergers & Acquisitions](https://www.august-debouzy.com/en/tax-expertise/mergers-acquisitions/)

### Sector

1

- [Life sciences & Healthcare](https://www.august-debouzy.com/en/tax-secteur/sante-et-pharma_en/)

## Discover more content that might interest you

News

[27/08/26 Deal 1 min August Debouzy advises Etherna Immunotherapies on its combination with Valerio Therapeutics to accelerate the development of targeted RNA-based therapies August Debouzy advised Etherna Immunotherapies on its proposed acquisition by Valerio Therapeutics. The €30 million transaction, supported by a €40.25 million PIPE financing, will create an integrated biotechnology company focused on RNA-based medicines. Read more](https://www.august-debouzy.com/en/deal/august-debouzy-advises-etherna-immunotherapies-on-its-combination-with-valerio-therapeutics-to-accelerate-the-development-of-targeted-rna-based-therapies/)
[15/05/24 Deal 2 min August Debouzy has assisted the Clariane Group in entering into exclusive negotiations for the planned sale of its Hospital at Home (HAD) business in France August Debouzy has assisted Clariane, a global care, healthcare and hospitality group listed on Euronext Paris, in signing a put option agreement with Fond Read more](https://www.august-debouzy.com/en/deal/august-debouzy-has-assisted-the-clariane-group-in-entering-into-exclusive-negotiations-for-the-planned-sale-of-its-hospital-at-home-had-business-in-france/)